- Home
- ALGS vs BOWN Comparison
ALGS vs BOWN Comparison
Compare ALGS & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- BOWN
- Stock Information
- Founded
- ALGS 2018
- BOWN 2023
- Country
- ALGS United States
- BOWN United States
- Employees
- ALGS N/A
- BOWN N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- BOWN
- Sector
- ALGS Health Care
- BOWN
- Exchange
- ALGS Nasdaq
- BOWN Nasdaq
- Market Cap
- ALGS 38.8M
- BOWN 36.1M
- IPO Year
- ALGS 2020
- BOWN 2023
- Fundamental
- Price
- ALGS $7.14
- BOWN $7.36
- Analyst Decision
- ALGS Strong Buy
- BOWN
- Analyst Count
- ALGS 1
- BOWN 0
- Target Price
- ALGS $70.00
- BOWN N/A
- AVG Volume (30 Days)
- ALGS 140.5K
- BOWN 374.5K
- Earning Date
- ALGS 03-10-2025
- BOWN 01-01-0001
- Dividend Yield
- ALGS N/A
- BOWN N/A
- EPS Growth
- ALGS N/A
- BOWN N/A
- EPS
- ALGS N/A
- BOWN 0.39
- Revenue
- ALGS $3,945,000.00
- BOWN N/A
- Revenue This Year
- ALGS $580.86
- BOWN N/A
- Revenue Next Year
- ALGS N/A
- BOWN N/A
- P/E Ratio
- ALGS N/A
- BOWN $20.26
- Revenue Growth
- ALGS N/A
- BOWN N/A
- 52 Week Low
- ALGS $6.76
- BOWN $2.71
- 52 Week High
- ALGS $46.80
- BOWN $11.00
- Technical
- Relative Strength Index (RSI)
- ALGS 24.28
- BOWN 62.05
- Support Level
- ALGS $10.45
- BOWN $7.15
- Resistance Level
- ALGS $9.76
- BOWN $8.89
- Average True Range (ATR)
- ALGS 1.11
- BOWN 1.09
- MACD
- ALGS 0.15
- BOWN 0.30
- Stochastic Oscillator
- ALGS 2.13
- BOWN 68.46
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.